These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 11728453

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Non-steroidal anti-inflammatory drugs suppress the ERK signaling pathway via block of Ras/c-Raf interaction and activation of MAP kinase phosphatases.
    Pan MR, Chang HC, Hung WC.
    Cell Signal; 2008 Jun; 20(6):1134-41. PubMed ID: 18374541
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cyclooxygenase-2 inhibitor NS398 enhances antitumor effect of irradiation on hormone refractory human prostate carcinoma cells.
    Wen B, Deutsch E, Eschwege P, De Crevoisier R, Nasr E, Eschwege F, Bourhis J.
    J Urol; 2003 Nov; 170(5):2036-9. PubMed ID: 14532848
    [Abstract] [Full Text] [Related]

  • 6. Induction of RECK by nonsteroidal anti-inflammatory drugs in lung cancer cells.
    Liu LT, Chang HC, Chiang LC, Hung WC.
    Oncogene; 2002 Nov 28; 21(54):8347-50. PubMed ID: 12447698
    [Abstract] [Full Text] [Related]

  • 7. Cyclin-dependent kinase 9 is required for tumor necrosis factor-alpha-stimulated matrix metalloproteinase-9 expression in human lung adenocarcinoma cells.
    Shan B, Zhuo Y, Chin D, Morris CA, Morris GF, Lasky JA.
    J Biol Chem; 2005 Jan 14; 280(2):1103-11. PubMed ID: 15528190
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Induction of apoptosis by cyclo-oxygenase-2 inhibitor NS398 through a cytochrome C-dependent pathway in esophageal cancer cells.
    Li M, Wu X, Xu XC.
    Int J Cancer; 2001 Jul 15; 93(2):218-23. PubMed ID: 11410869
    [Abstract] [Full Text] [Related]

  • 10. Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells.
    Abiru S, Nakao K, Ichikawa T, Migita K, Shigeno M, Sakamoto M, Ishikawa H, Hamasaki K, Nakata K, Eguchi K.
    Hepatology; 2002 May 15; 35(5):1117-24. PubMed ID: 11981761
    [Abstract] [Full Text] [Related]

  • 11. The nonsteroidal anti-inflammatory drug NS398 reactivates SPARC expression via promoter demethylation to attenuate invasiveness of lung cancer cells.
    Pan MR, Chang HC, Chuang LY, Hung WC.
    Exp Biol Med (Maywood); 2008 Apr 15; 233(4):456-62. PubMed ID: 18367635
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. COX-2 inhibitors suppress lung cancer cell growth by inducing p21 via COX-2 independent signals.
    Han S, Roman J.
    Lung Cancer; 2006 Mar 15; 51(3):283-96. PubMed ID: 16376453
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. p16 inhibits matrix metalloproteinase-2 expression via suppression of Sp1-mediated gene transcription.
    Wang CH, Chang HC, Hung WC.
    J Cell Physiol; 2006 Jul 15; 208(1):246-52. PubMed ID: 16575904
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.